Comparison of the levels of anti-amyloid β 42 antibody, amyloid β 40, amyloid β 42 and interleukin 8 in cerebrospinal fluid and serum samples between the patient with cerebral amyloid angiopathy-related inflammation and control subjects. This evidence concerns the gene CXCL8 and cerebral amyloid angiopathy.